Nippon Shokubai Co. Ltd. (TYO:4114) has been actively refocusing its efforts under its “Reborn Nippon Shokubai 2020” long-term business plan…....

Japan's leading chemical industry newspaper

Filed Under: Interviews Tagged With: active pharmaceutical ingredients, advanced materials, business plans, drug discovery, interview, medical, Nippon Shokubai, SAP, Sirrus, Yujiro Goto
Nippon Shokubai Co. Ltd. (TYO:4114) has been actively refocusing its efforts under its “Reborn Nippon Shokubai 2020” long-term business plan…....